WILMINGTON, N.C., July 27, 2009 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that it plans to release second quarter 2009 financial results after market close on Thursday, July 30, 2009. Rick Randall, President and Chief Executive Officer of TranS1, and Mike Luetkemeyer, Chief Financial Officer, will host a conference call starting at 4:30 pm ET on the same day. The call will be concurrently webcast. To listen to the conference call on your telephone, please dial 888-228-5279 for domestic callers and 913-312-1520 for international callers approximately ten minutes prior to the start time. To access the live audio broadcast or the subsequent archived recording, visit the TranS1 Web site at http://www.trans1.com under the investor relations section.
About TranS1 Inc.
TranS1 is a medical device company focused on designing, developing and marketing products that implement its proprietary minimally invasive surgical approach to treat degenerative disc disease and instability affecting the lower lumbar region of the spine. TranS1 currently markets two single-level fusion products, the AxiaLIF(r) and the AxiaLIF 360(tm), and a two-level fusion product, the AxiaLIF 2L(tm), in the U.S. and Europe. TranS1 was founded in May 2000 and is headquartered in Wilmington, North Carolina.
For more information, visit www.trans1.com.